CATHETRIX Foley Catheter Securement Device to be Distributed in Three Markets

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

November 6, 2019

CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixations, has signed an agreement with Pro-Lab Diagnostics, a global distributor of medical products, for the distribution of CATHETRIXS innovative FoleySafe catheter securement device in Canada, United States, and the United Kingdom.

CATHETRIX notes the FoleySafe is the world’s first catheter stabilizer which actively prevents possible damage to the bladder and urethra from accidental urinary catheter extraction.

The company has recently won an establishment license for its products from Health Canada. The device has already been patented and received U.S. FDA and EU CE Mark clearances.

Pro-Lab Diagnostics, which has its head office in Ontario, Canada, with branches in the US and the UK and many global affiliates, is already negotiating several agreements for the sale of FoleySafe.

“We have witnessed great interest in FoleySafe from hospitals and retirement home centers looking for a reliable and cost-effective solution to the disturbing problem of accidental self-extraction of Foley catheters,” said Robert Rae, Pro-Lab Diagnostics President & CEO. “Our distributors have already started a pilot project at a couple of Canadian health institutions.”

“The agreement with Pro-Lab Diagnostics, with their leading position in North America and the UK, will enable us to introduce the ground breaking FoleySafe to these large markets,” said Robert Baum, director of marketing at CATHETRIX. “There is great interest in our catheter securement device, and we will soon reveal additional global distribution agreements.”

FoleySafe will be demonstrated at MEDICA 2019, which will take place November 18–21 in Dusseldorf, Germany. Medical equipment distributors, urologists and medical providers are invited to CATHETRIX booth M25 in Hall 16 to observe demonstrations.

FoleySafe prevents accidental urinary catheter extraction, thus avoiding possible damage to the bladder and urethra. Once the Foley catheter is pulled with a force that can harm the patient, FoleySafe will cut the sterile fluid tube and let the retention balloon deflate, permitting the catheter to slide out safely.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.